Canagliflozin mediated dual inhibition of mitochondrial glutamate dehydrogenase and complex I: an off-target adverse effect
2018 · Cell Death and Disease · 81 citations
https://doi.org/10.1038/s41419-018-0273-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
1.2K
Citations
17
h-index
19
i10-index
Simon Gutbier is an academic researcher from Roche (Switzerland). The author has contributed to research in topics: Neuroinflammation and Neurodegeneration Mechanisms & Neuroscience and Neuropharmacology Research & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 17, co-authored 28 publications.
ORCID: 0000-0001-8014-0801https://doi.org/10.1038/s41419-018-0273-y
https://doi.org/10.1038/s41418-018-0229-x
https://doi.org/10.1007/s00204-018-2326-5
Click to start Chat